FDA Wants New Warnings On Prostate Cancer Drugs
The U.S. Food and Drug Administration on Wednesday recommended new warning labels for certain prostate cancer drugs sold by Pfizer Inc., Bayer AG and others to inform consumers about the potential...To view the full article, register now.
Already a subscriber? Click here to view full article